bioAffinity Technologies, Inc. Current Assets
bioAffinity Technologies, Inc. (BIAF) had Current Assets of $3.87 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-07
- 2026-06-30: Assets, Current $3.87M.
- 2026-03-31: Assets, Current $4.34M.
- 2025-12-31: Assets, Current $7.57M.
- 2025-09-30: Assets, Current $8.61M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $3.87M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $4.34M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $7.57M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $8.61M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.67M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.86M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.70M 10-K · filed 2026-03-16 |
| 2024-09-30 | $2.55M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.68M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $3.93M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $3.97M 10-K · filed 2025-03-31 |
| 2023-09-30 | $6.01M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $8.66M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $10.23M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $11.96M 10-K · filed 2024-04-01 |
| 2022-09-30 | $14.05M 10-Q · filed 2022-11-14 |
| 2021-12-31 | $1.44M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |